BTL Industries v. Be Minked Beauty: Emsculpt RF Patent Suit Dismissed
BTL Industries, Inc. brought an infringement action against Be Minked Beauty & Company LLC in Indiana’s Northern District Court, asserting patent US10478634B2 covering the Emsculpt RF body-contouring machine. The case closed just 61 days after filing when BTL voluntarily dismissed without prejudice under Fed. R. Civ. P. 41(a)(1)(A)(i).
Emsculpt RF infringement claim dropped in 61 days — but the door stays open
On 20 December 2024, BTL Industries, Inc. — a medical aesthetics technology company and holder of US10478634B2 covering the Emsculpt RF body-contouring and muscle-stimulation device — filed an infringement action against Be Minked Beauty & Company LLC and individual Britney Humphrey in the Northern District of Indiana. The complaint alleged infringement of the asserted patent in connection with defendants’ use or operation of an Emsculpt RF Machine.
The case ended on 19 February 2025 when BTL filed a notice of voluntary dismissal without prejudice pursuant to Fed. R. Civ. P. 41(a)(1)(A)(i). This procedural mechanism — available to a plaintiff before a defendant serves an answer or a motion for summary judgment — terminates the action without any ruling on the merits and, critically, without prejudice, meaning BTL retains the legal right to refile substantially the same claims against the same defendants at a future date.
The 61-day duration suggests the case resolved — or was tactically paused — well before standard litigation milestones such as a scheduling order, claim construction, or substantive motion practice. The public record does not disclose whether the parties reached a private agreement, a licensing arrangement, or whether BTL simply chose to reassess its enforcement strategy. The absence of any defendant representation on the docket is consistent with a very early-stage proceeding.
Filing to Voluntary dismissal in 61 days
61 days — faster than the median district court patent case by a wide margin
Voluntarily dismissed: what Rule 41 without prejudice means for both parties
Rule 41(a)(1)(A)(i): plaintiff’s unilateral exit before answer
Fed. R. Civ. P. 41(a)(1)(A)(i) allows a plaintiff to dismiss an action without a court order at any time before the defendant serves an answer or a summary judgment motion. BTL exercised this right here. The dismissal is self-executing — no judge approval is required — and carries no merits determination. The court never adjudicated infringement, validity, or claim scope.
No merits rulingThe public record confirms: dismissed without prejudice
A dismissal without prejudice means the plaintiff is not barred from refiling the same claims. BTL’s notice expressly states ‘without prejudice,’ so this case does not extinguish BTL’s infringement claims against Be Minked Beauty or Britney Humphrey. Had the dismissal been with prejudice, it would have operated as a final judgment on the merits, preventing refiling. The docket here clearly specifies the more permissive without-prejudice variant.
Refiling permittedDefendants face no judgment — but uncertainty persists
Be Minked Beauty & Company LLC and Britney Humphrey obtained no declaratory judgment of non-infringement or invalidity. While the immediate litigation threat has lifted, the without-prejudice dismissal means BTL could recommence action. Defendants may wish to seek legal clarity on their use of the Emsculpt RF technology or consider a freedom-to-operate review to reduce future exposure.
No declaratory reliefEarly dismissal suggests leverage, licensing, or strategy shift
Cases dismissed this quickly — before any defendant appearance — typically suggest one of three scenarios: a private settlement or licensing agreement was reached; BTL identified a procedural or strategic reason to pause; or the action was filed as a deterrent. None of these can be confirmed from the public record alone. For other Emsculpt RF operators in the aesthetics sector, BTL’s active enforcement posture signals ongoing IP monitoring of downstream device usage.
Enforcement signalFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | BTL Industries, Inc. | Company | Medical aesthetics technology company — holder of US10478634B2 (Emsculpt RF)Search in Eureka ↗ |
| Defendant | Be Minked Beauty & Company LLC | Company | Beauty and aesthetics service provider allegedly operating Emsculpt RF equipmentSearch in Eureka ↗ |
| Plaintiff counsel | D. Randall Brown | Attorney | Counsel for BTL Industries, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Michael E. Wever | Attorney | Counsel for BTL Industries, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Barnes & Thornburg, LLP | Law Firm | Representing BTL Industries, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Indiana Northern District CourtSearch in Eureka ↗ |
Official order — verbatim text
BTL’s notice of voluntary dismissal without prejudice is a procedural termination, not a substantive ruling. The court made no finding on infringement, patent validity, or claim construction. The express invocation of Rule 41(a)(1)(A)(i) confirms this was plaintiff-initiated before any answer was served, preserving BTL’s full right to refile. The silence of any defendant counsel on the docket is consistent with a proceeding that ended before the defendants were required to formally appear.
US10478634B2 — Emsculpt RF electromagnetic muscle stimulation device
US10478634B2, filed under application number US16/034793, protects technology relating to the Emsculpt RF Machine — a non-invasive medical aesthetics device that combines high-intensity focused electromagnetic (HIFEM) energy with radiofrequency (RF) energy to simultaneously stimulate muscle contractions and reduce adipose tissue. The patent sits within the medical device and energy-based aesthetics treatment domain, a rapidly expanding commercial field driven by consumer demand for non-surgical body-contouring procedures.
For BTL Industries, this patent represents a core asset in its flagship Emsculpt product line, which competes directly against a growing number of RF and electromagnetic stimulation devices in the medical aesthetics market. Enforcement of this patent against downstream operators — rather than only competing manufacturers — suggests BTL may be pursuing a broader IP monetisation or market-control strategy. Competitors and device distributors operating in the HIFEM-RF space should monitor claim scope carefully, as this category of device IP has strong commercial leverage.
Should you run an FTO against US10478634B2 before operating Emsculpt RF?
Any clinic, medical spa, beauty operator, or distributor deploying electromagnetic muscle stimulation or RF body-contouring devices should assess their exposure to US10478634B2. BTL’s willingness to file against even small single-operator businesses signals that device use — not just manufacture — may be within the enforcement scope. An FTO review is particularly relevant for businesses operating branded or third-party Emsculpt RF equipment, or any HIFEM-RF combination device.
PatSnap Eureka’s FTO Search Agent can map the claims of US10478634B2 against your specific device or treatment protocol, identify relevant prior art that may affect enforceability, and flag any continuation or divisional patents in the same family. This provides a defensible paper trail for procurement teams, compliance officers, and legal counsel before a demand letter arrives.
Run a freedom-to-operate analysis on US10478634B2 to assess your product’s exposure
Run FTO in Eureka →Similar patent cases: medical aesthetics device IP in US district courts
Explore related infringement actions involving electromagnetic muscle stimulation, RF body-contouring, and medical aesthetics device patents filed in US district courts.
What this case signals for the medical aesthetics IP landscape
BTL’s rapid-fire enforcement and quick withdrawal is a pattern worth tracking across the aesthetics device sector.
Without-prejudice dismissals are enforcement tools, not concessions
A Rule 41(a)(1)(A)(i) dismissal without prejudice costs BTL nothing in terms of future legal rights. It is a low-risk enforcement tactic — file, apply pressure, then withdraw if a resolution is reached privately. Aesthetics device operators should treat such filings as credible signals of an active licensing or enforcement programme, not as cases that ‘went away.’
US10478634B2 remains fully enforceable after this dismissal
Because the case ended without any challenge to patent validity or claim scope, US10478634B2 has not been weakened. No IPR was filed, no invalidity defence was litigated. The patent continues to carry full presumption of validity. Businesses operating body-contouring or electromagnetic muscle stimulation devices should assess whether their use falls within the claim scope.
BTL v Be — key questions answered
The case was dismissed without prejudice. BTL Industries filed a notice of voluntary dismissal expressly stating ‘without prejudice’ under Fed. R. Civ. P. 41(a)(1)(A)(i). This means the dismissal carries no res judicata effect and BTL retains the right to refile the same infringement claims against Be Minked Beauty & Company LLC and Britney Humphrey.
BTL Industries asserted US10478634B2, filed under application number US16/034793. The patent covers technology related to the Emsculpt RF Machine — a non-invasive body-contouring device combining high-intensity focused electromagnetic (HIFEM) energy and radiofrequency (RF) energy for simultaneous muscle stimulation and fat reduction.
The public record does not disclose the reason. Cases dismissed under Rule 41(a)(1)(A)(i) within 61 days of filing typically suggest a private resolution — such as a licensing agreement or settlement — a strategic reassessment by plaintiff, or a deterrence-oriented filing. No merits adjudication occurred, so no court findings are available to indicate either side’s relative strength.
No. The dismissal without prejudice carries no ruling on patent validity or enforceability. No invalidity defence was litigated and no IPR petition was filed. US10478634B2 retains its full statutory presumption of validity under 35 U.S.C. § 282. The patent remains a live enforcement asset for BTL Industries.
The dismissal without prejudice does not grant defendants any licence, clearance, or declaratory judgment of non-infringement. BTL retains the right to refile. Defendants obtained no legal certainty from this outcome. Any continued operation of the Emsculpt RF Machine should ideally be supported by independent legal advice or a freedom-to-operate analysis to assess ongoing exposure under US10478634B2.
PatSnap Eureka searches patents and litigation data to answer instantly.